APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Lung Image Analysis

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Lung Image Analysis Market Outlook and Growth Opportunities 2026

15 January 2026195 pages

Choose your research edition.

Industry ResearchAI Lung Image Analysis Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Lung Image Analysis Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal AI Lung Image Analysis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Lung Image Analysis Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Lung Image Analysis Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global AI Lung Image Analysis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Lung Image Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Lung Image Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Lung Image Analysis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Lung Image Analysis market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Lung Image Analysis market include GE HealthCare, Siemens Healthineers, Thirona, Philips Healthcare, Infervision, DeepWise, Huiying Medical, Aidoc and Lunit, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Lung Image Analysis market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Lung Image Analysis and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Lung Image Analysis revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Lung Image Analysis market.

AI Lung Image Analysis Segment by Company

GE HealthCare

Siemens Healthineers

Thirona

Philips Healthcare

Infervision

DeepWise

Huiying Medical

Aidoc

Lunit

Canon Medical Systems

Riverain Technologies

VoxelCloud

QUIBIM

Shukun Technology

AI Lung Image Analysis Segment by Type

2D Analysis

3D Analysis

AI Lung Image Analysis Segment by Application

Hospital

Clinic

Research Institution

Other

AI Lung Image Analysis Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Lung Image Analysis status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Lung Image Analysis key companies, revenue, market share, and recent developments.

3. To split the AI Lung Image Analysis breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Lung Image Analysis market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Lung Image Analysis significant trends, drivers, influence factors in global and regions.

6. To analyze AI Lung Image Analysis competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Lung Image Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Lung Image Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Lung Image Analysis.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Lung Image Analysis industry.

Chapter 3: Detailed analysis of AI Lung Image Analysis company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Lung Image Analysis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Lung Image Analysis in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Lung Image Analysis Industry Trends Table 2. AI Lung Image Analysis Industry Drivers Table 3. AI Lung Image Analysis Industry Opportunities and Challenges Table 4. AI Lung Image Analysis Industry Restraints Table 5. Global AI Lung Image Analysis Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Lung Image Analysis Revenue Share by Company (2021-2026) Table 7. Global AI Lung Image Analysis Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Lung Image Analysis Key Company Manufacturing Base & Headquarters Table 9. Global AI Lung Image Analysis Company, Product Type & Application Table 10. Global AI Lung Image Analysis Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Lung Image Analysis by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of 2D Analysis Table 15. Significant Companies of 3D Analysis Table 16. Global AI Lung Image Analysis Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global AI Lung Image Analysis Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global AI Lung Image Analysis Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global AI Lung Image Analysis Sales Value Share by Type (2021-2026) Table 20. Global AI Lung Image Analysis Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Significant Companies of Research Institution Table 24. Significant Companies of Other Table 25. Global AI Lung Image Analysis Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global AI Lung Image Analysis Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global AI Lung Image Analysis Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global AI Lung Image Analysis Sales Value Share by Application (2021-2026) Table 29. Global AI Lung Image Analysis Sales Value Share by Application (2027-2032) Table 30. Global AI Lung Image Analysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Lung Image Analysis Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global AI Lung Image Analysis Sales Value Share by Region (2021-2026) Table 33. Global AI Lung Image Analysis Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global AI Lung Image Analysis Sales Value Share by Region (2027-2032) Table 35. Global AI Lung Image Analysis Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global AI Lung Image Analysis Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global AI Lung Image Analysis Sales Value Market Share by Country (2021-2026) Table 38. Global AI Lung Image Analysis Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global AI Lung Image Analysis Sales Value Market Share by Country (2027-2032) Table 40. GE HealthCare Company Information Table 41. GE HealthCare Business Overview Table 42. GE HealthCare AI Lung Image Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. GE HealthCare AI Lung Image Analysis Product Portfolio Table 44. GE HealthCare Recent Development Table 45. Siemens Healthineers Company Information Table 46. Siemens Healthineers Business Overview Table 47. Siemens Healthineers AI Lung Image Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Siemens Healthineers AI Lung Image Analysis Product Portfolio Table 49. Siemens Healthineers Recent Development Table 50. Thirona Company Information Table 51. Thirona Business Overview Table 52. Thirona AI Lung Image Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Thirona AI Lung Image Analysis Product Portfolio Table 54. Thirona Recent Development Table 55. Philips Healthcare Company Information Table 56. Philips Healthcare Business Overview Table 57. Philips Healthcare AI Lung Image Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Philips Healthcare AI Lung Image Analysis Product Portfolio Table 59. Philips Healthcare Recent Development Table 60. Infervision Company Information Table 61. Infervision Business Overview Table 62. Infervision AI Lung Image Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Infervision AI Lung Image Analysis Product Portfolio Table 64. Infervision Recent Development Table 65. DeepWise Company Information Table 66. DeepWise Business Overview Table 67. DeepWise AI Lung Image Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. DeepWise AI Lung Image Analysis Product Portfolio Table 69. DeepWise Recent Development Table 70. Huiying Medical Company Information Table 71. Huiying Medical Business Overview Table 72. Huiying Medical AI Lung Image Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Huiying Medical AI Lung Image Analysis Product Portfolio Table 74. Huiying Medical Recent Development Table 75. Aidoc Company Information Table 76. Aidoc Business Overview Table 77. Aidoc AI Lung Image Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Aidoc AI Lung Image Analysis Product Portfolio Table 79. Aidoc Recent Development Table 80. Lunit Company Information Table 81. Lunit Business Overview Table 82. Lunit AI Lung Image Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Lunit AI Lung Image Analysis Product Portfolio Table 84. Lunit Recent Development Table 85. Canon Medical Systems Company Information Table 86. Canon Medical Systems Business Overview Table 87. Canon Medical Systems AI Lung Image Analysis Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Canon Medical Systems AI Lung Image Analysis Product Portfolio Table 89. Canon Medical Systems Recent Development Table 90. Riverain Technologies Company Information Table 91. Riverain Technologies Business Overview Table 92. Riverain Technologies AI Lung Image Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Riverain Technologies AI Lung Image Analysis Product Portfolio Table 94. Riverain Technologies Recent Development Table 95. VoxelCloud Company Information Table 96. VoxelCloud Business Overview Table 97. VoxelCloud AI Lung Image Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. VoxelCloud AI Lung Image Analysis Product Portfolio Table 99. VoxelCloud Recent Development Table 100. QUIBIM Company Information Table 101. QUIBIM Business Overview Table 102. QUIBIM AI Lung Image Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. QUIBIM AI Lung Image Analysis Product Portfolio Table 104. QUIBIM Recent Development Table 105. Shukun Technology Company Information Table 106. Shukun Technology Business Overview Table 107. Shukun Technology AI Lung Image Analysis Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Shukun Technology AI Lung Image Analysis Product Portfolio Table 109. Shukun Technology Recent Development Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. AI Lung Image Analysis Product Image Figure 2. Global AI Lung Image Analysis Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Lung Image Analysis Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Lung Image Analysis Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. 2D Analysis Image Figure 8. 3D Analysis Image Figure 9. Global AI Lung Image Analysis Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global AI Lung Image Analysis Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global AI Lung Image Analysis Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Research Institution Image Figure 15. Other Image Figure 16. Global AI Lung Image Analysis Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global AI Lung Image Analysis Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global AI Lung Image Analysis Sales Value Share by Application (2021-2032) Figure 19. Global AI Lung Image Analysis Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global AI Lung Image Analysis Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America AI Lung Image Analysis Sales Value (2021-2032) & (US$ Million) Figure 22. North America AI Lung Image Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe AI Lung Image Analysis Sales Value (2021-2032) & (US$ Million) Figure 24. Europe AI Lung Image Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific AI Lung Image Analysis Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific AI Lung Image Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America AI Lung Image Analysis Sales Value (2021-2032) & (US$ Million) Figure 28. South America AI Lung Image Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa AI Lung Image Analysis Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa AI Lung Image Analysis Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt AI Lung Image Analysis Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • 2D Analysis
  • 3D Analysis
Applications
  • Hospital
  • Clinic
  • Research Institution
  • Other
Companies covered
  • GE HealthCare
  • Siemens Healthineers
  • Thirona
  • Philips Healthcare
  • Infervision
  • DeepWise
  • Huiying Medical
  • Aidoc
  • Lunit
  • Canon Medical Systems
  • Riverain Technologies
  • VoxelCloud
  • QUIBIM
  • Shukun Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Lung Image Analysis Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Lung Image Analysis Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Lung Image Analysis Market Dynamics
  1. 2.1 AI Lung Image Analysis Industry Trends
  2. 2.2 AI Lung Image Analysis Industry Drivers
  3. 2.3 AI Lung Image Analysis Industry Opportunities and Challenges
  4. 2.4 AI Lung Image Analysis Industry Restraints
3 AI Lung Image Analysis Market by Company
  1. 3.1 Global AI Lung Image Analysis Company Revenue Ranking in 2025
  2. 3.2 Global AI Lung Image Analysis Revenue by Company (2021-2026)
  3. 3.3 Global AI Lung Image Analysis Company Ranking (2024-2026)
  4. 3.4 Global AI Lung Image Analysis Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Lung Image Analysis Company Product Type and Application
  6. 3.6 Global AI Lung Image Analysis Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Lung Image Analysis Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Lung Image Analysis Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Lung Image Analysis Market by Type
  1. 4.1 AI Lung Image Analysis Type Introduction
  2. 4.1.1 2D Analysis
  3. 4.1.2 3D Analysis
  4. 4.2 Global AI Lung Image Analysis Sales Value by Type
  5. 4.2.1 Global AI Lung Image Analysis Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global AI Lung Image Analysis Sales Value by Type (2021-2032)
  7. 4.2.3 Global AI Lung Image Analysis Sales Value Share by Type (2021-2032)
5 AI Lung Image Analysis Market by Application
  1. 5.1 AI Lung Image Analysis Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Research Institution
  5. 5.1.4 Other
  6. 5.2 Global AI Lung Image Analysis Sales Value by Application
  7. 5.2.1 Global AI Lung Image Analysis Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global AI Lung Image Analysis Sales Value by Application (2021-2032)
  9. 5.2.3 Global AI Lung Image Analysis Sales Value Share by Application (2021-2032)
6 AI Lung Image Analysis Regional Value Analysis
  1. 6.1 Global AI Lung Image Analysis Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Lung Image Analysis Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Lung Image Analysis Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Lung Image Analysis Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Lung Image Analysis Sales Value (2021-2032)
  7. 6.3.2 North America AI Lung Image Analysis Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Lung Image Analysis Sales Value (2021-2032)
  10. 6.4.2 Europe AI Lung Image Analysis Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Lung Image Analysis Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Lung Image Analysis Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Lung Image Analysis Sales Value (2021-2032)
  16. 6.6.2 South America AI Lung Image Analysis Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Lung Image Analysis Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Lung Image Analysis Sales Value Share by Country, 2025 VS 2032
7 AI Lung Image Analysis Country-level Value Analysis
  1. 7.1 Global AI Lung Image Analysis Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Lung Image Analysis Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Lung Image Analysis Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Lung Image Analysis Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Lung Image Analysis Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Lung Image Analysis Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Lung Image Analysis Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GE HealthCare
  2. 8.1.1 GE HealthCare Company Information
  3. 8.1.2 GE HealthCare Business Overview
  4. 8.1.3 GE HealthCare AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GE HealthCare AI Lung Image Analysis Product Portfolio
  6. 8.1.5 GE HealthCare Recent Developments
  7. 8.2 Siemens Healthineers
  8. 8.2.1 Siemens Healthineers Company Information
  9. 8.2.2 Siemens Healthineers Business Overview
  10. 8.2.3 Siemens Healthineers AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Siemens Healthineers AI Lung Image Analysis Product Portfolio
  12. 8.2.5 Siemens Healthineers Recent Developments
  13. 8.3 Thirona
  14. 8.3.1 Thirona Company Information
  15. 8.3.2 Thirona Business Overview
  16. 8.3.3 Thirona AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Thirona AI Lung Image Analysis Product Portfolio
  18. 8.3.5 Thirona Recent Developments
  19. 8.4 Philips Healthcare
  20. 8.4.1 Philips Healthcare Company Information
  21. 8.4.2 Philips Healthcare Business Overview
  22. 8.4.3 Philips Healthcare AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Philips Healthcare AI Lung Image Analysis Product Portfolio
  24. 8.4.5 Philips Healthcare Recent Developments
  25. 8.5 Infervision
  26. 8.5.1 Infervision Company Information
  27. 8.5.2 Infervision Business Overview
  28. 8.5.3 Infervision AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Infervision AI Lung Image Analysis Product Portfolio
  30. 8.5.5 Infervision Recent Developments
  31. 8.6 DeepWise
  32. 8.6.1 DeepWise Company Information
  33. 8.6.2 DeepWise Business Overview
  34. 8.6.3 DeepWise AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
  35. 8.6.4 DeepWise AI Lung Image Analysis Product Portfolio
  36. 8.6.5 DeepWise Recent Developments
  37. 8.7 Huiying Medical
  38. 8.7.1 Huiying Medical Company Information
  39. 8.7.2 Huiying Medical Business Overview
  40. 8.7.3 Huiying Medical AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Huiying Medical AI Lung Image Analysis Product Portfolio
  42. 8.7.5 Huiying Medical Recent Developments
  43. 8.8 Aidoc
  44. 8.8.1 Aidoc Company Information
  45. 8.8.2 Aidoc Business Overview
  46. 8.8.3 Aidoc AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Aidoc AI Lung Image Analysis Product Portfolio
  48. 8.8.5 Aidoc Recent Developments
  49. 8.9 Lunit
  50. 8.9.1 Lunit Company Information
  51. 8.9.2 Lunit Business Overview
  52. 8.9.3 Lunit AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Lunit AI Lung Image Analysis Product Portfolio
  54. 8.9.5 Lunit Recent Developments
  55. 8.10 Canon Medical Systems
  56. 8.10.1 Canon Medical Systems Company Information
  57. 8.10.2 Canon Medical Systems Business Overview
  58. 8.10.3 Canon Medical Systems AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Canon Medical Systems AI Lung Image Analysis Product Portfolio
  60. 8.10.5 Canon Medical Systems Recent Developments
  61. 8.11 Riverain Technologies
  62. 8.11.1 Riverain Technologies Company Information
  63. 8.11.2 Riverain Technologies Business Overview
  64. 8.11.3 Riverain Technologies AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Riverain Technologies AI Lung Image Analysis Product Portfolio
  66. 8.11.5 Riverain Technologies Recent Developments
  67. 8.12 VoxelCloud
  68. 8.12.1 VoxelCloud Company Information
  69. 8.12.2 VoxelCloud Business Overview
  70. 8.12.3 VoxelCloud AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
  71. 8.12.4 VoxelCloud AI Lung Image Analysis Product Portfolio
  72. 8.12.5 VoxelCloud Recent Developments
  73. 8.13 QUIBIM
  74. 8.13.1 QUIBIM Company Information
  75. 8.13.2 QUIBIM Business Overview
  76. 8.13.3 QUIBIM AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
  77. 8.13.4 QUIBIM AI Lung Image Analysis Product Portfolio
  78. 8.13.5 QUIBIM Recent Developments
  79. 8.14 Shukun Technology
  80. 8.14.1 Shukun Technology Company Information
  81. 8.14.2 Shukun Technology Business Overview
  82. 8.14.3 Shukun Technology AI Lung Image Analysis Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Shukun Technology AI Lung Image Analysis Product Portfolio
  84. 8.14.5 Shukun Technology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst